Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
About this item
Full title
Author / Creator
Publisher
United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
Coronavirus disease 2019 (COVID‐19) is associated with adverse outcomes, including need for invasive mechanical ventilation and death in people with risk factors. Liver enzyme elevation is commonly seen in this group, but its clinical significance remains elusive. In this study, we calculated the Fibrosis‐4 (FIB‐4) score for a cohort of hospitalize...
Alternative Titles
Full title
Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_46a0d9b59f724909b303bbb9ef723bc8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_46a0d9b59f724909b303bbb9ef723bc8
Other Identifiers
ISSN
2471-254X
E-ISSN
2471-254X
DOI
10.1002/hep4.1650
